Nitro-dur Patch
Product Images NDC 50742-513

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Nitro-dur (NDC 50742-513). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nitroglycerin Chemical Structure (Nitro Dur 01)

Chemical structure diagram showing a molecule with H2CONO2 and HCONO2 groups, likely related to nitroglycerin, the active ingredient in NITRO-DUR transdermal patches by Ingenus Pharmaceuticals.*

FDA Label Image

Cross Section Of System (Nitro Dur 02)

An illustration of a transdermal patch showing its layered construction. The top layer is labeled 'Impermeable Backing,' and below it is a layer labeled 'Nitroglycerin/Adhesive,' indicating the patch contains nitroglycerin embedded in an adhesive for skin application.*

FDA Label Image

Placement Area Image (Nitro Dur 03)

An instructional diagram showing the correct placement of a transdermal patch on the upper chest area of a person. The illustration highlights a gray patch placed on the upper chest, just below the neck and to the left side.*

FDA Label Image

Application Figure Image (Nitro Dur 04)

An instructional illustration showing hands applying or removing a circular transdermal patch, likely demonstrating proper use or handling of the product.*

FDA Label Image

Application Figure Image (Nitro Dur 05)

Instructional illustration showing hands applying or removing a NITRO-DUR transdermal patch, depicting the method for correct placement or removal from the skin. The image includes a close-up outline of a body area, likely the chest or upper arm, where the patch is to be applied.*

FDA Label Image

Application Figure Image (Nitro Dur 06)

An instructional illustration showing the application of a transdermal patch. The diagram depicts a person placing a rectangular patch on the upper arm or shoulder area, demonstrating proper placement for a NITRO-DUR nitroglycerin transdermal patch.*

FDA Label Image

Application Figure Image (Nitro Dur 07)

An instructional illustration showing a hand applying a round transdermal patch to the skin, likely demonstrating how to use a nitroglycerin patch such as NITRO-DUR. The image is in grayscale and depicts the patch placement technique.*

FDA Label Image

Application Figure Image (Nitro Dur 08)

An instructional diagram showing a hand applying a circular patch to the skin, illustrating the proper method to remove the protective backing from a transdermal patch before application. No specific product branding is visible in the image itself.*

FDA Label Image

Application Figure Image (Nitro Dur 09)

An illustration demonstrating the proper application of the NITRO-DUR transdermal patch on the upper arm. The diagram shows a person placing the patch on the skin, highlighting the location and method for usage of the nitroglycerin patch. No additional textual information is visible.*

FDA Label Image

Application Figure Image (Nitro Dur 10)

NITRO-DUR nitroglycerin transdermal patch packaging shows a primarily white and gray background with the patch partially visible on the right side of the image. There is a circular cut-out on the left. The labeler is Ingenus Pharmaceuticals, LLC. Specific strength or quantity details are not visible.*

FDA Label Image

Removal Figure Image (Nitro Dur 11)

An instructional illustration showing a hand holding a NITRO-DUR transdermal patch. The image depicts application steps, including handling the patch carefully by its edges and preparing it for placement on the skin.*

FDA Label Image

Removal Figure Image (Nitro Dur 12)

An instructional illustration showing a hand holding a round transdermal patch with a peel-off backing. The image demonstrates the removal of the protective liner from the adhesive patch, typically used for applying a nitroglycerin patch such as NITRO-DUR.*

FDA Label Image

20 mg Pouch Box (Nitro Dur 13 V01)

NITRO-DUR (nitroglycerin) transdermal patch packaging label showing a 0.1 mg/hr (5 cm²) dosage strength. The label includes usage directions, manufacturer Ingenus Pharmaceuticals, LLC, and states the product is for human prescription use only. It features unit dosage information and space for serialization details.*

FDA Label Image

40 mg Pouch Box (Nitro Dur 14 V01)

NITRO-DUR (nitroglycerin) transdermal patch packaging label from Ingenus Pharmaceuticals, LLC. The label specifies a 0.2 mg/hr (10 cm²) strength and indicates it is a transdermal infusion system. The label includes usage directions, quantity of 30 units, and notes each patch contains 40 mg nitroglycerin in an acrylic-based polymer matrix. It clearly states Rx only and includes a barcode and various handling instructions.*

FDA Label Image

60 mg Pouch Box (Nitro Dur 15 V01)

NITRO-DUR (nitroglycerin) 0.3 mg/hr (15 cm²) transdermal patch packaging label. The label includes directions for use, product strength, NDC 60742-515-30, and contents of 30 units. It is labeled as a transdermal infusion system by Ingenus Pharmaceuticals, LLC, for prescription use only.*

FDA Label Image

80 mg Pouch Box (Nitro Dur 16 V01)

Packaging label for Nitro-Dur (nitroglycerin) Transdermal Infusion System patch, 0.4 mg/hr strength delivering dose over 20 cm². The label shows the product name, active ingredient, dosage form, route, labeler Ingenus Pharmaceuticals, LLC, and directions for use. It indicates a carton containing 30 units with detailed instructions for application and disposal.*

FDA Label Image

120 mg Pouch Box (Nitro Dur 17 V01)

NITRO-DUR nitroglycerin transdermal infusion system patch, 0.6 mg/hr (30 cm²), shown in its unfolded carton packaging design. The label indicates a 120 mg content per unit, with usage directions, manufacturer Ingenus Pharmaceuticals, LLC, and an NDC barcode. The packaging is primarily purple with black and white text, including dosing and application instructions.*

FDA Label Image

160 mg Pouch Box (Nitro Dur 18 V01)

NITRO-DUR 0.8 mg/hr (40 cm²) transdermal patch packaging label by Ingenus Pharmaceuticals, LLC. The label shows the product name, nitroglycerin as the active ingredient, dosage and delivery rate, package contents of 30 units, usage directions, and a barcode. It includes regulatory information, serialization space, and a peel seal area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.